INSIGHTS ON CLINICAL TRIAL PARTNERING

• Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies

  Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.

• Why Asia Should Be Your Next Trial Destination

  Many U.S. oncology sponsors are expanding their late-phase trials into Asia to secure access to rich patient pools, leverage efficient regulatory pathways, and save time and money in the clinic.

• Rapid Startup Phase 1 Cardiomyopathy CRISPR Gene Therapy

  Hereditary transthyretin amyloidosis (ATTRv) is very rare, prompting a Phase 1 trial of in vivo CRISPR/Cas9 gene editing to reduce mutant protein and stop cardiomyopathy progression.

• Phase 1 Trial In Painful Diabetic Peripheral Neuropathy

  A complex Phase 1 neuropathy study with overnight stays achieved full enrollment and retention through careful planning, strong participant engagement, and disciplined operational execution.

• Clinical, Commercial Packaging: Delivering Next-Gen Therapies

  4/7/2026

  See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

• 2025 Clinical Trial Payment Tax Implications Explained

  10/8/2025

  Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.

• Considerations For Drug-Device Combination Products In Rare Diseases

  8/7/2025

  The development process for these products is complex, requiring careful consideration of regulatory requirements, technical feasibility, clinical efficacy, and patient-centered design.

• Center Of Excellence For Clinical Supply Packaging

  3/24/2026

  Strategic facility placement and cold chain expertise enable trial sponsors to reach diverse patient populations while supporting decentralized distribution models for temperature-sensitive therapies.

• Technology Fragmentation Is One Of The Biggest Hidden Risks In Clinical Trials

  4/6/2026

  Reclaim your research day by reducing manual data entry. Learn how connecting operational and financial workflows eases administrative burdens and supports site sustainability.